Clinical Trial Update: Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of cariprazine in adolescents (13-17 years) with schizophrenia. The study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Gedeon Richter Plc. | Conditions: Schizophrenia | Phase 3 | Status: RECRUITING